Liaoning Chengda Biotechnology Co., Ltd.

¥20.79As of Sun 8 Nov 2026, 12:00 UTC
SSE:688739Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (21.65%)
Div yield 0.48%
ROE 0.69%
Biotechnology
Beta (5Y) 0.42
PE TTM 130.9
TSR TTM (23.82%)
Mkt cap ¥8.541B
ROIC 0.16%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
22.83%
(88.30%)
Hold 9|9|7|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.21
0.22
0.25
0.24
11.46%
17.08%
37.03%
20.54%
Revenue¥B
1.062
1.093
1.094
1.120
2.34%
3.68%
0.20%
4.36%
Peers (US$1.280B)
Cap (US$)
PE
1.316B
122.1x
1.308B
39.02x
1.277B
—
Capital
TTM
5Y
10Y
Leveragex
5.341
0.341
0.243
EBIT/Intx
6.202
0.149
0.169
Own earn%
50.21
(47.09)
(47.29)
Sh yield%
32.22
20.84
19.33
Owners
Insiders/Inst%
7.45
25.61
Short interest%
5.59
SBC / revenue%
5.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
7